Used in pharmaceutical research as a key intermediate in the synthesis of antifungal agents, particularly in the development of triazole-based drugs. Its structure supports activity against fungal pathogens by inhibiting essential enzyme systems involved in ergosterol biosynthesis. Commonly explored in the design of new antifungal therapeutics with improved potency and reduced resistance. Also utilized in structure-activity relationship (SAR) studies to optimize drug candidates targeting fungal infections.